Resultados de la búsqueda 1-10 of 4978 for hla genotype

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  5. Síndrome de Stevens-Johnson - Síntomas y causas - Mayo Clinic

    ... HLA-B*1502 antes de iniciar el tratamiento. Si tuviste ... HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: A systematic review.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  7. Transplant Center de Mayo Clinic - Ensayos clínicos

    The purpose of this study is to evaluate the utility of using anti-HLA antibody titer to measure the effectiveness of antibody lowering therapy (i.e., ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  9. Síndrome de Stevens-Johnson - Diagnóstico y tratamiento - Mayo Clinic

    HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: A systematic review. Clinical Pharmacology and Therapeutics. 2012;92:757. Wetter DA ...

  10. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...